Oxcarbazepine Suspension
Product Images NDC 68094-123

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 68094-123). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Precision Dose, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Oxcarb 01)

Chemical structure of oxcarbazepine showing its molecular framework with two benzene rings fused to a seven-membered ring containing a ketone group and an amide side chain.*

FDA Label Image

Figure 1 (Oxcarb 02)

A Kaplan-Meier curve comparing exit rates over time between oxcarbazepine and placebo treatment groups. The x-axis represents time on trial in days from Day 2 to Day 11, and the y-axis shows the exit rate from 0.0 to 1.0. Oxcarbazepine group is depicted with a solid line, placebo with a dashed line. The chart includes a log-rank test p-value of 0.0001 indicating statistical comparison between groups.*

FDA Label Image

Figure 2 (Oxcarb 03)

A Kaplan-Meier curve chart showing seizure rate over time from first dose to first seizure days for treatment groups Oxcarbazepine and Placebo. The x-axis represents days from 1st dose to 1st seizure, and the y-axis shows seizure rate. The graph compares seizure rates between Oxcarbazepine and Placebo groups with a log-rank test p-value of 0.046.*

FDA Label Image

Figure 3 (Oxcarb 04)

A Kaplan-Meier curve chart displaying exit rate over time (days) for two treatment groups labeled HIGH and LOW. The x-axis represents time to exit in days, ranging from 0 to 130. The y-axis shows the exit rate, ranging from 0.0 to 1.0. The LOW group (dotted line) shows a faster increase in exit rate than the HIGH group (solid line). A log-rank test with a p-value of 0.0001 is noted on the graph.*

FDA Label Image

Figure 4 (Oxcarb 05)

A Kaplan-Meier curve graph showing exit rate over time (days) for two treatment groups labeled as HIGH and LOW. The y-axis represents exit rate from 0.0 to 1.0, and the x-axis represents time to exit in days from 0 to 130. The LOW group shows a steeper increase in exit rate early on compared to the HIGH group. A log-rank test p-value of 0.0001 is indicated on the graph.*

FDA Label Image

Principal Display Panel (5 mL Cup Label)

Label for Oxcarbazepine oral suspension, USP 300 mg/5 mL by Precision Dose, Inc. The label includes the NDC 68094-123-59, states the volume delivered is 5 mL, and provides storage instructions to store at 20° to 25°C (68° to 77°F). It also includes a barcode and indicates the product is prescription only (Rx Only).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.